Is milrinone contraindicated in a patient with shock and hypertrophic obstructive cardiomyopathy (HOCM)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, milrinone is contraindicated in shock patients with HOCM.

Intravenous positive inotropic drugs including milrinone are potentially harmful for the treatment of acute hypotension in patients with obstructive HCM 1. The FDA drug label explicitly states that milrinone should not be used in patients with severe obstructive aortic or pulmonic valvular disease and may aggravate outflow tract obstruction in hypertrophic subaortic stenosis 2.

Why Milrinone is Harmful in HOCM with Shock

The pathophysiology explains the contraindication clearly:

  • Milrinone increases contractility through phosphodiesterase-3 inhibition, which worsens the dynamic left ventricular outflow tract (LVOT) obstruction that defines HOCM 2
  • Milrinone causes vasodilation, which drops systemic vascular resistance and can precipitate catastrophic hypotension in patients who already have compromised cardiac output from LVOT obstruction 3, 2
  • The combination of increased contractility (worsening obstruction) and decreased afterload (dropping blood pressure) creates a hemodynamic disaster in HOCM patients

What to Use Instead

For acute hypotension in obstructive HCM, intravenous phenylephrine (or another pure vasoconstrictor without inotropic activity) is recommended 1, 4. This approach:

  • Increases systemic vascular resistance to support blood pressure
  • Does NOT increase contractility (avoiding worsening of LVOT obstruction)
  • Should be combined with aggressive fluid resuscitation as first-line therapy 1

Avoid ALL positive inotropes in HOCM with shock, including:

  • Dopamine
  • Dobutamine
  • Norepinephrine (has inotropic effects)
  • Epinephrine
  • Milrinone 1

Critical Pitfall

The natural instinct when seeing "shock" is to reach for inotropes. This is exactly wrong in HOCM. The obstruction IS the problem - making the heart squeeze harder only makes things worse. Think of it as trying to push more water through a kinked hose by increasing the pressure - you need to unkink the hose (reduce obstruction with vasoconstrictors and volume) rather than increase the pump pressure.

Pure vasoconstrictors like phenylephrine work by increasing afterload, which paradoxically improves forward flow by reducing the dynamic LVOT gradient 1, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.